Skip to content

Early Diagnosis of Breast Cancer-related Lymphedema

Early Diagnosis of Breast Cancer-related Lymphedema

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06046365
Enrollment
300
Registered
2023-09-21
Start date
2022-10-24
Completion date
2026-12-31
Last updated
2025-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema

Keywords

lymphoedema, limb circumference, tissue hardness

Brief summary

This study will conduct clinical trials to explore the mechanisms behind the development of upper limb lymphedema following breast cancer surgery. The investigators will recruit patients who have undergone breast cancer surgery and utilize Indocyanine Green (ICG) lymphography and Lymphoscintigraphy to identify the locations of lymphatic blockages. Shear Wave Elastography (SWE) will be used to detect changes in tissue limb compliance. DXA body composition analysis will measure the differences in the composition ratios between edematous and normal limbs. In addition, diffusion correlation spectrometry will be employed to monitor changes in deep tissue blood flow, complemented by continuous measurements of limb circumference and other physiological parameters. The study aims to explore the interrelationships among lymphatic circulation, limb circumference, tissue compliance, and tissue blood flow rates.

Detailed description

Breast cancer ranks as the most common cancer among women in Taiwan. According to the cancer registry data of Taiwan's Ministry of Health and Welfare, there were 16,325 new cases of breast cancer in 2016. Approximately one in 12 women will develop breast cancer in her lifetime. Although the incidence rate is high, the survival rate after clinical treatment is also quite high. The five-year survival rate for early-stage breast cancer patients exceeds 90%, making it a highly manageable disease at present. The incidence rate of breast cancer-related lymphedema is around 21.4%, and is expected to become increasingly common as the survival rate of patients improves. Aside from causing psychological distress, it also impairs a patient's work and daily life capabilities. Patients also have to bear additional medical expenses, which brings a significant financial burden to families. Current research supports that early detection and treatment are key to controlling breast cancer-related lymphedema. However, there is still a need for a clearer understanding of the risk factors causing lymphedema and the physiological changes that occur when it manifests, in order to achieve the goal of early detection. This study will conduct clinical trials to investigate the mechanisms of upper limb lymphedema after breast cancer surgery. The investigators will recruit post-operative breast cancer patients and use Indocyanine Green (ICG) lymphography and Lymphoscintigraphy to detect lymphatic blockage locations; Shear Wave Elastography (SWE) to detect changes in tissue limb compliance; DXA body composition analysis to measure the differences in edema and normal limb composition ratios; and diffusion correlation spectrometry to measure deep tissue blood flow changes, along with continuous measurements of limb circumference and other physiological parameters. The study aims to explore the interrelationship among lymphatic circulation, limb circumference, tissue compliance, and tissue blood flow. The expected results of this study can help the investigators understand the risk factors causing lymphedema and the physiological changes that occur when it manifests, overcome the current difficulties in early lymphedema detection, and develop effective monitoring methods and equipment. This will provide more possibilities for the early detection and treatment of future patients with breast cancer-related lymphedema.

Interventions

DIAGNOSTIC_TESTlymphoscintigraphy

lymphoscintigraphy

DIAGNOSTIC_TESTcircumference measurement

circumference measurement

DIAGNOSTIC_TESTsonography

B-mode sono and elastography

DIAGNOSTIC_TESTDXA body composition analysis

DXA body composition analysis

Sponsors

Kaohsiung Veterans General Hospital.
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Female patients who are expected to undergo breast cancer resection surgery or have already undergone breast resection surgery for breast cancer. * Absence of unhealed open wounds or other conditions unsuitable for tactile measurements within the measurement area. * No severe cognitive or emotional impairments. * No substance abuse (alcohol or drugs). * Females aged between 20 and 80, capable of fully complying with the requirements of this study plan.

Exclusion criteria

* Presence of unhealed open wounds or other conditions unsuitable for tactile measurements within the measurement area. * Upper limb abnormalities in function (including joint mobility and muscle strength). * Significant cognitive, auditory, or expressive language issues that hinder comprehension and compliance with instructions. * Lack of assistance for daily measurements.

Design outcomes

Primary

MeasureTime frameDescription
circumferenceeveryday, through study completion, an average of 1 yearCircumference measurements are taken and recorded at 2 cm intervals from the wrist crease to the armpit on both upper limbs
Tissue complianceevery 1 week, through study completion, an average of 1 yearMeasurements are taken every 5 cm from the wrist crease to the armpit on both upper limbs using ShearWave Elastography
LymphoscintigraphyOnce at the beginning of the study, and another assessment will be conducted six months later if there is a deterioration in lymphedemaGolden Standard for diagnosing lymphedema, used for detecting the location of lymphatic circulation blockage
Indocyanine green (ICG) lymphographyOnce at the beginning of the study, and another assessment will be conducted 3 months later if there is a deterioration in lymphedemaRoutine examination, used for detecting the type of lymphatic blockage
DXA body composition analysisOnce at the beginning of the study, and another assessment will be conducted 3 months later if there is a deterioration in lymphedemaUsing DXA to detect and compare the composition of both limbs at different stages after the onset of lymphedema, including changes in protein, fat, and mineral density

Countries

Taiwan

Contacts

Primary ContactZheng Yu Hoe
jhoe@vghks.gov.tw+886935517631

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026